authors
- Brade, AM
- Magalhaes, J
- Siu, L
- Oza, A
- Lovell, S
- de Borja, M
- Pond, Gregory
- Sherman, I
- Hedley, D
- Chen, E
A single agent, phase I pharmacodynamic study of nimotuzumab (TheraClM-h-R3) in patients with advanced refractory solid tumors
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 20, 2007
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal